Nutralife Biosciences Insiders

Nutralife Biosciences employs about 12 people. The company is managed by 4 executives with a total tenure of roughly 23 years, averaging almost 5.0 years of service per executive, having 3.0 employees per reported executive. Breaking down Nutralife Biosciences' management performance can provide insight into the firm performance.
Edgar Ward  CEO
President CEO, Director
Kenneth Duchin  President
Vice President - Clinical Development
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Nutralife Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.2848) % which means that it has lost $0.2848 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (14.2602) %, meaning that it created substantial loss on money invested by shareholders. Nutralife Biosciences' management efficiency ratios could be used to measure how well Nutralife Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Nutralife Biosciences Workforce Comparison

Nutralife Biosciences is regarded second in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 81.0. Nutralife Biosciences retains roughly 12.0 in number of employees claiming about 15% of equities under Drug Manufacturers—Specialty & Generic industry.

Nutralife Biosciences Notable Stakeholders

A Nutralife Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nutralife Biosciences often face trade-offs trying to please all of them. Nutralife Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nutralife Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Edgar WardPresident CEO, DirectorProfile
Kenneth DuchinVice President - Clinical DevelopmentProfile
Hongxiang MDChief BoardProfile
Nicholas WardProject MangProfile

Nutralife Biosciences Workforce Analysis

Traditionally, organizations such as Nutralife Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nutralife Biosciences within its industry.

Nutralife Biosciences Manpower Efficiency

Return on Nutralife Biosciences Manpower

Revenue Per Employee52.2K
Revenue Per Executive156.7K
Net Loss Per Employee485.6K
Net Loss Per Executive1.5M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Nutralife Pink Sheet

If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm